-
1
-
-
0023853769
-
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs
-
Farde L, Wiesel FA, Halldin C, Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 1988;45:71-6.
-
(1988)
Arch Gen Psychiatry
, vol.45
, pp. 71-76
-
-
Farde, L.1
Wiesel, F.A.2
Halldin, C.3
Sedvall, G.4
-
2
-
-
0022370639
-
Neuroleptic malignant syndrome
-
Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985;142:1137-45
-
(1985)
Am J Psychiatry
, vol.142
, pp. 1137-1145
-
-
Levenson, J.L.1
-
3
-
-
0000637447
-
Neuroleptic malignant syndrome: Diagnostic issues
-
Caroff SN, Mann SC, Lazarus S, Sullivan K, MacFadden W. Neuroleptic malignant syndrome: diagnostic issues. Psychiatr Ann 1991;21:130-47.
-
(1991)
Psychiatr Ann
, vol.21
, pp. 130-147
-
-
Caroff, S.N.1
Mann, S.C.2
Lazarus, S.3
Sullivan, K.4
MacFadden, W.5
-
5
-
-
0022503130
-
Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital
-
Pope HG, Keck PE, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 1986;143:1227-33.
-
(1986)
Am J Psychiatry
, vol.143
, pp. 1227-1233
-
-
Pope, H.G.1
Keck, P.E.2
McElroy, S.L.3
-
6
-
-
0028114486
-
An overview of the mechanism of action of clozapine
-
Melzer HY. An overview of the mechanism of action of clozapine. J Clin Psychiatry 1994;55(9, suppl B):47-52.
-
(1994)
J Clin Psychiatry
, vol.55
, Issue.9 SUPPL. B
, pp. 47-52
-
-
Melzer, H.Y.1
-
9
-
-
0024268376
-
Neuroleptic malignant syndrome after clozapine plus carbamazepine
-
Muller T, Becker T, Fritze J. Neuroleptic malignant syndrome after clozapine plus carbamazepine (letter). Lancet 1988;2:1500.
-
(1988)
Lancet
, vol.2
, pp. 1500
-
-
Muller, T.1
Becker, T.2
Fritze, J.3
-
10
-
-
0027439255
-
Neuroleptic malignant syndrome associated with clozapine monotherapy
-
Thornberg SA, Ereshefsky L. Neuroleptic malignant syndrome associated with clozapine monotherapy. Pharmacotherapy 1993:13:510-4.
-
(1993)
Pharmacotherapy
, vol.13
, pp. 510-514
-
-
Thornberg, S.A.1
Ereshefsky, L.2
-
12
-
-
0025763958
-
Neuroleptic malignant syndrome associated with clozapine use
-
Anderson ES, Powers PS. Neuroleptic malignant syndrome associated with clozapine use. J Clin Psychiatry 1991:52:102-4.
-
(1991)
J Clin Psychiatry
, vol.52
, pp. 102-104
-
-
Anderson, E.S.1
Powers, P.S.2
-
13
-
-
0025854204
-
Clozapine-induced neuroleptic malignant syndrome
-
DasGupta K, Young A. Clozapine-induced neuroleptic malignant syndrome. J Clin Psychiatry 1991:52:105-7.
-
(1991)
J Clin Psychiatry
, vol.52
, pp. 105-107
-
-
DasGupta, K.1
Young, A.2
-
14
-
-
0025839795
-
Neuroleptic malignant syndrome (NMS) with clozapine monotherapy and benign hyperthermia in a post-NMS period with clozapine
-
Vetter P, Proppe D, Hoppe-Seyler S. Neuroleptic malignant syndrome (NMS) with clozapine monotherapy and benign hyperthermia in a post-NMS period with clozapine. Nervenarzt 1991;62:55-7.
-
(1991)
Nervenarzt
, vol.62
, pp. 55-57
-
-
Vetter, P.1
Proppe, D.2
Hoppe-Seyler, S.3
-
15
-
-
0025647208
-
Atypical neuroleptic malignant syndrome (NMS) with an atypical neuroleptic: Clozapine-induced NMS without rigidity
-
Nopoulos P, Flaum M, Miller DD. Atypical neuroleptic malignant syndrome (NMS) with an atypical neuroleptic: clozapine-induced NMS without rigidity. Ann Clin Psychiatry 1990;2:251-3.
-
(1990)
Ann Clin Psychiatry
, vol.2
, pp. 251-253
-
-
Nopoulos, P.1
Flaum, M.2
Miller, D.D.3
-
16
-
-
0026589349
-
An apparent neuroleptic malignant syndrome without extrapyramidal symptoms upon initiation of clozapine therapy: Report of a case and results of clozapine rechallenge
-
Goates MG, Escobar JI. An apparent neuroleptic malignant syndrome without extrapyramidal symptoms upon initiation of clozapine therapy: report of a case and results of clozapine rechallenge (letter). J Clin Psychopharmacol 1992;12:139-40.
-
(1992)
J Clin Psychopharmacol
, vol.12
, pp. 139-140
-
-
Goates, M.G.1
Escobar, J.I.2
-
18
-
-
0027531861
-
Does clozapine cause neuroleptic malignant syndrome ?
-
Weller M, Kornhuber J. Does clozapine cause neuroleptic malignant syndrome (letter)? J Clin Psychiatry 1993;54:70-1.
-
(1993)
J Clin Psychiatry
, vol.54
, pp. 70-71
-
-
Weller, M.1
Kornhuber, J.2
-
20
-
-
0003845629
-
-
Bethesda, MD: American Society of Health-System Pharmacists
-
McEvory GK, Litvak K, Welsh OH, eds. AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists, 1995:1530.
-
(1995)
AHFS Drug Information.
, pp. 1530
-
-
McEvory, G.K.1
Litvak, K.2
Welsh, O.H.3
-
21
-
-
0028359567
-
The side effects of clozapine: A four year follow-up study
-
Marinkovic D, Timotijevic I, Babinski T, Totoic S, Paunovic VR. The side effects of clozapine: a four year follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:537-44.
-
(1994)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.18
, pp. 537-544
-
-
Marinkovic, D.1
Timotijevic, I.2
Babinski, T.3
Totoic, S.4
Paunovic, V.R.5
-
23
-
-
0026775271
-
NMS and lethal catatonia
-
Weller M. NMS and lethal catatonia (leter). J Clin Psychiatry 1992;53:294.
-
(1992)
J Clin Psychiatry
, vol.53
, pp. 294
-
-
Weller, M.1
-
24
-
-
0028213782
-
Clinical pharmacokinetics of antipsychotics
-
Javaid JI. Clinical pharmacokinetics of antipsychotics. J Clin Pharmacol 1994;34:286-95.
-
(1994)
J Clin Pharmacol
, vol.34
, pp. 286-295
-
-
Javaid, J.I.1
-
25
-
-
0026476484
-
Clozapine rechallenge after an episode of neuroleptic malignant syndrome
-
Weller M, Kornhuber J. Clozapine rechallenge after an episode of neuroleptic malignant syndrome. Br J Psychiatry 1992;161:855-6.
-
(1992)
Br J Psychiatry
, vol.161
, pp. 855-856
-
-
Weller, M.1
Kornhuber, J.2
|